This inventor holds 1 USPTO granted patent. Top assignees: Anges, Inc., Osaka University, Takara Bio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 1,043 
1 out of 150 Years Active: 2026
Title: Hisato Ikai: Innovator in DNA Vaccine Development
Introduction
Hisato Ikai is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work has the potential to impact public health positively.
Latest Patents
Hisato Ikai holds a patent for an "Improved DNA Vaccine for SARS-CoV-2." This invention represents a crucial advancement in the fight against the COVID-19 pandemic. The patent showcases his commitment to addressing global health challenges through innovative solutions.
Career Highlights
Throughout his career, Ikai has worked with esteemed institutions, including Osaka University and Takara Bio Inc. His experiences in these organizations have equipped him with the knowledge and skills necessary to excel in his field. His work has been instrumental in advancing vaccine technology.
Collaborations
Due to space limitations, the collaborations section will be omitted.
Conclusion
Hisato Ikai's contributions to vaccine development, particularly his patent for an improved DNA vaccine, highlight his role as an innovator in biotechnology. His work continues to inspire advancements in public health and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile